Announcements, outreach, and conversations from B1Neuro. We share milestones, community work, and talks from our team as they happen.

FEATURED · 9 JULY 2026

A patient’s journey through the APIC-TMS trial

For people with treatment-resistant depression, standard treatment may not be enough. Raj shares his journey through Personalised Transcranial Magnetic Stimulation, piloted by the Institute of Mental Health and NUS Medicine, in partnership with Temasek Foundation.
[Read coverage from Temasek Foundation’s 2026 report →]

Talks and Videos

A patient’s journey through the APIC-TMS trial

For people with treatment-resistant depression, standard treatment may not be enough. Raj shares his journey through Personalised Transcranial Magnetic Stimulation.

A Retiree’s Battle With Depression and Anxiety

Geriatric mental-health conditions often have a profound impact on individuals and families. Philip shares his journey, coming from a generation where mental illnesses aren’t spoken about.

Personalized TMS treatment for Depression

▶

B1Neuro’s founders explain how they use functional MRI to guide Transcranial Magnetic Stimulation (TMS), a non-invasive and drug-free alternative for patients unresponsive to medication.

Southeast Asia’s first personalised TMS trials

B1Neuro’s team provides the technology behind APIC-TMS and SPARK-D, two clinical trials evaluating personalized TMS for treatment-resistant depression – a first of their kind in the region.

News

2026

Media coverage

Jul 2026: Dr Tor Phern Chern speaks about personalized TMS in Temasek Foundation’s 2026 review
[Read coverage from Temasek Foundation’s 2026 report →]